Alaunos Therapeutics, Inc. (TCRT) NASDAQ
2.75
-0.12(-4.18%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.29M |
| Enterprise Value | 4.91M |
| P/E Ratio | -1.3 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 2,238.63 |
| Price/Book Ratio | 4.16 |
| Enterprise/Revenue | 2,120.63 |
| Enterprise/EBITDA | -1.55 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1,369.67 |
| Operating Margin | -1,381.67 |
Management Effectiveness
| Return On Assets | -2.18 |
| Return On Equity | -1.66 |
Income Statement
| Revenue | 5,000 |
| Revenue/Share | 0 |
| Gross Profit | 5,000 |
| EBITDA | -4.22M |
| Net Income | -4.18M |
| Diluted EPS | -2.2 |
Balance Sheet
| Total Cash | 354,000 |
| Total Cash/Share | 0.18 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.63 |
| Book Value Per Share | 0.66 |
Price History
| 52-Week Change | 1.85 |
| 52-Week High | 6.2 |
| 52-Week Low | 1.67 |
| Moving Average 50 Days | 2.76 |
| Moving Average 200 Days | 2.89 |
Statistics
| Average Volume | 15,817 |
| Shares Outstanding | 2.44M |
| % Held by Institutions | 6.46 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 18, 2024 |
